Mifepristone at a concentration of 20 μM effectively reduced collective migration and scattering of oral cancer cells, consistent with the suppression of the PI3K-Akt and MAPK signalling pathways, and reduced expression of N-Cadherin. Here, CDH2 is linked to lip and oral cavity carcinoma.